Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cequa (cyclosporine ophthalmic emulsion) vs hyaluronic acid in perioperative cataract patients with dry eye
ChiCTR2600120872Phase 4Recruiting
- Sponsor
- Changzhou Third People's Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciclosporin in cataract and dry eye syndrome (DED) (2 arms), sponsored by Changzhou Third People's Hospital. Primary endpoints: Tear Film Break-Up Time and Ocular Surface Disease Index. Started Mar 2026; status: recruiting.
02
Drugs
ciclosporin
03
Conditions
cataractdry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2600120872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120872.